查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1591985

免疫蛋白市场：按产品、应用和最终用户划分 - 全球预测 2025-2030

Immunoprotein Market by Product (C3, C4, Free Light Chains), Application (Allergy Testing, Autoimmune Testing, Infectious Disease Testing), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年免疫蛋白市值为196.4亿美元，预计2024年将达到215.4亿美元，复合年增长率为10.16%，到2030年将达到386.7亿美元。

免疫蛋白是指参与身体免疫反应的蛋白质，如免疫球蛋白、细胞激素、补体蛋白等。免疫蛋白的市场范围涵盖诊断、治疗和研究应用。对它的需求正在增加，因为它在自体免疫疾病、过敏、感染疾病和癌症的诊断和治疗中发挥着重要作用。在诊断学中，它们作为评估免疫系统功能的生物标记物，而在治疗学中，源自免疫蛋白的单株抗体对于标靶治疗至关重要。最终用途包括临床实验室、医院、研究机构等。市场成长是由生物技术和基因组学的进步、慢性病的增加以及个人化医疗的需求所推动的。关键的成长机会在于开发利用免疫蛋白的新型治疗方法和照护现场诊断工具。然而，高昂的研发成本、严格的法律规范以及可扩展性和可重复性问题等挑战正在阻碍市场进步。测试方法标准化有限也可能影响市场的可靠性和可信度。为了抓住新的机会，相关人员应该投资合作研究，以创新更安全、更有效的免疫蛋白解决方案，并加强利用巨量资料的生物资讯技术能力。向开拓的应用领域（例如神经退化性疾病）的多元化可能会提供开拓的成长潜力。此外，扩大新兴市场进入可以刺激医疗基础设施已开发地区的需求。创新可能集中在提高免疫测量的特异性和灵敏度，以及为资源匮乏的环境开发具有成本效益的携带式诊断试剂套件。市场竞争激烈，策略联盟和收购突出，以加强产品平臺和市场占有率。透过持续创新和策略调整来应对当前挑战，公司可以最大限度地发挥免疫蛋白的潜力，并巩固其在动态医疗保健环境中的地位。

主要市场统计
基准年[2023] 196.4亿美元
预测年份 [2024] 215.4亿美元
预测年份 [2030] 386.7亿美元
复合年增长率（%） 10.16%

市场动态：揭示快速发展的免疫蛋白市场的关键市场洞察

供需的动态交互作用正在改变免疫蛋白市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 感染疾病和慢性病的发生率和盛行率增加
    • 世界上老年人数量不断增加，诊断测试数量不断增加
    • 偏好快速、准确的疾病诊断
  • 市场限制因素
    • 与常规微生物检测相比，免疫蛋白检测成本较高
  • 市场机会
    • 免疫诊断设备的技术进步
    • 为发现严重的治疗方法而进行的有效研究和开发工作
  • 市场问题
    • 替代测试方法的可用性

波特五力：驾驭免疫蛋白市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点，避免潜在的挑战，确保更强大的市场地位。

PESTLE分析：了解免疫蛋白市场的外部影响

外部宏观环境因素在塑造免疫蛋白市场的表现动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析：了解免疫蛋白质市场的竞争格局

免疫蛋白市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：免疫蛋白市场供应商的绩效评估

FPNV 定位矩阵是评估免疫蛋白市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製免疫蛋白市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，对免疫蛋白市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争格局中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1. 市场渗透率：详细检视当前市场环境，主要企业的广泛资料，评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、主要产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 感染疾病和慢性病的发生率和盛行率增加
      • 随着世界各地老年人数量的增加，诊断测试也在增加。
      • 优先考虑快速且准确的疾病诊断
    • 抑制因素
      • 免疫蛋白测试比常规微生物测试更昂贵
    • 机会
      • 免疫诊断设备的技术进步
      • 为发现严重的治疗方法而进行的有效研究和开发工作
    • 任务
      • 替代测试方法的可用性
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章免疫蛋白市场：副产品

  • 介绍
  • C3
  • C4
  • 游离轻链
  • 结合球蛋白
  • 免疫球蛋白A
  • 特异性IgE
  • 总免疫球蛋白E
  • IgG
  • IgM
  • 免疫固定法
  • 前白蛋白
  • 蛋白质电泳

第七章免疫蛋白质市场：依应用分类

  • 介绍
  • 过敏测试
  • 自体免疫测试
  • 传染病检查
  • 肿瘤学和内分泌学测试

第八章免疫蛋白市场：依最终用户分类

  • 介绍
  • 医院/诊所

第九章美洲免疫蛋白市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太免疫蛋白市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲免疫蛋白市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Amgen Inc.
  • Celltrion Healthcare Co., Ltd.
  • Eli Lilly and Company
  • Entera Health, Inc.
  • Genentech, Inc. by F. Hoffmann-La Roche Ltd
  • Glaxosmithkline PLC
  • Merck KGaA
  • Neurobiologix, Inc.
  • Novartis AG
  • Pfizer Inc.
  • Progurt Inc.
  • Samsung Biologics by Samsung Electronics Co., Ltd.
  • SERO AS
  • TECHNOPATH Distribution Ltd. by Diploma PLC
  • Teva Pharmaceutical Industries Ltd.
Product Code: MRR-43127F7279D3

The Immunoprotein Market was valued at USD 19.64 billion in 2023, expected to reach USD 21.54 billion in 2024, and is projected to grow at a CAGR of 10.16%, to USD 38.67 billion by 2030.

Immunoprotein refers to proteins involved in the body's immune response, including immunoglobulins, cytokines, and complement proteins. The market scope for immunoproteins extends across diagnostics, therapeutics, and research applications. Necessity arises from their critical role in diagnosing and treating autoimmune diseases, allergies, infections, and cancer. In diagnostics, they serve as biomarkers to assess immune system function, while in therapeutics, monoclonal antibodies derived from immunoproteins are pivotal in targeted therapies. The end-use scope includes clinical laboratories, hospitals, and research institutions. Market growth is driven by advances in biotechnology and genomics, the increasing prevalence of chronic diseases, and demand for personalized medicine. Key growth opportunities lie in the development of novel therapies and point-of-care diagnostic tools leveraging immunoproteins. However, challenges such as high R&D costs, stringent regulatory frameworks, and issues of scalability and reproducibility hinder progress in the market. Limited standardization in testing methodologies can also affect the market's credibility and reliability. To seize emerging opportunities, stakeholders should invest in collaborative research to innovate safer, more effective immunoprotein-based solutions and enhance technological capabilities in bioinformatics to harness big data. Diversification into underexplored applications, such as neurodegenerative diseases, could offer untapped potential for growth. Additionally, expanding access to emerging markets can fuel demand where healthcare infrastructure is evolving. Innovation could focus on improving the specificity and sensitivity of immunoassays and developing cost-effective, portable diagnostic kits for lower-resource settings. The market nature is competitive, marked by strategic partnerships and acquisitions to bolster product pipelines and market share. By addressing current challenges through continuous innovation and strategic adaptation, businesses can leverage immunoproteins' full potential, solidifying their position in a dynamic healthcare landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 19.64 billion
Estimated Year [2024] USD 21.54 billion
Forecast Year [2030] USD 38.67 billion
CAGR (%) 10.16%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Immunoprotein Market

The Immunoprotein Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growth in incidence & prevalence of infectious and chronic diseases
    • Rising geriatric population across world and increase in diagnostic tests
    • Preferences for quick and accurate disease diagnosis
  • Market Restraints
    • Immunoprotein tests are costly as compared to routine microbiology assays
  • Market Opportunities
    • Technological advancements in immunodiagnostic instruments
    • Effective R&D efforts to discover therapeutics against critical disease
  • Market Challenges
    • Availability of alternative testing approaches

Porter's Five Forces: A Strategic Tool for Navigating the Immunoprotein Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Immunoprotein Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Immunoprotein Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Immunoprotein Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Immunoprotein Market

A detailed market share analysis in the Immunoprotein Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Immunoprotein Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Immunoprotein Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Immunoprotein Market

A strategic analysis of the Immunoprotein Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Immunoprotein Market, highlighting leading vendors and their innovative profiles. These include Amgen Inc., Celltrion Healthcare Co., Ltd., Eli Lilly and Company, Entera Health, Inc., Genentech, Inc. by F. Hoffmann-La Roche Ltd, Glaxosmithkline PLC, Merck KGaA, Neurobiologix, Inc., Novartis AG, Pfizer Inc., Progurt Inc., Samsung Biologics by Samsung Electronics Co., Ltd., SERO AS, TECHNOPATH Distribution Ltd. by Diploma PLC, and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Immunoprotein Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across C3, C4, Free Light Chains, Haptoglobin, IgA, IgE Specific, IgE Total, IgG, IgM, Immunofixation, Prealbumin, and Protein Electrophoresis.
  • Based on Application, market is studied across Allergy Testing, Autoimmune Testing, Infectious Disease Testing, and Oncology & Endocrinology Testing.
  • Based on End User, market is studied across Hospital & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growth in incidence & prevalence of infectious and chronic diseases
      • 5.1.1.2. Rising geriatric population across world and increase in diagnostic tests
      • 5.1.1.3. Preferences for quick and accurate disease diagnosis
    • 5.1.2. Restraints
      • 5.1.2.1. Immunoprotein tests are costly as compared to routine microbiology assays
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in immunodiagnostic instruments
      • 5.1.3.2. Effective R&D efforts to discover therapeutics against critical disease
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of alternative testing approaches
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Immunoprotein Market, by Product

  • 6.1. Introduction
  • 6.2. C3
  • 6.3. C4
  • 6.4. Free Light Chains
  • 6.5. Haptoglobin
  • 6.6. IgA
  • 6.7. IgE Specific
  • 6.8. IgE Total
  • 6.9. IgG
  • 6.10. IgM
  • 6.11. Immunofixation
  • 6.12. Prealbumin
  • 6.13. Protein Electrophoresis

7. Immunoprotein Market, by Application

  • 7.1. Introduction
  • 7.2. Allergy Testing
  • 7.3. Autoimmune Testing
  • 7.4. Infectious Disease Testing
  • 7.5. Oncology & Endocrinology Testing

8. Immunoprotein Market, by End User

  • 8.1. Introduction
  • 8.2. Hospital & Clinics

9. Americas Immunoprotein Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Immunoprotein Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Immunoprotein Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Amgen Inc.
  • 2. Celltrion Healthcare Co., Ltd.
  • 3. Eli Lilly and Company
  • 4. Entera Health, Inc.
  • 5. Genentech, Inc. by F. Hoffmann-La Roche Ltd
  • 6. Glaxosmithkline PLC
  • 7. Merck KGaA
  • 8. Neurobiologix, Inc.
  • 9. Novartis AG
  • 10. Pfizer Inc.
  • 11. Progurt Inc.
  • 12. Samsung Biologics by Samsung Electronics Co., Ltd.
  • 13. SERO AS
  • 14. TECHNOPATH Distribution Ltd. by Diploma PLC
  • 15. Teva Pharmaceutical Industries Ltd.

LIST OF FIGURES

  • FIGURE 1. IMMUNOPROTEIN MARKET RESEARCH PROCESS
  • FIGURE 2. IMMUNOPROTEIN MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL IMMUNOPROTEIN MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. IMMUNOPROTEIN MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. IMMUNOPROTEIN MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. IMMUNOPROTEIN MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL IMMUNOPROTEIN MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. IMMUNOPROTEIN MARKET DYNAMICS
  • TABLE 7. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY C3, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY C4, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY FREE LIGHT CHAINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY HAPTOGLOBIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY IGA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY IGE SPECIFIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY IGE TOTAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY IGG, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY IGM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY IMMUNOFIXATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY PREALBUMIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY PROTEIN ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY ALLERGY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY AUTOIMMUNE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY ONCOLOGY & ENDOCRINOLOGY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. INDIA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. INDIA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. INDONESIA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. INDONESIA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. INDONESIA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. JAPAN IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. JAPAN IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. JAPAN IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. MALAYSIA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. MALAYSIA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. MALAYSIA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. PHILIPPINES IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. PHILIPPINES IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. PHILIPPINES IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. SINGAPORE IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. SINGAPORE IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. SINGAPORE IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. SOUTH KOREA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. SOUTH KOREA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. SOUTH KOREA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. TAIWAN IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. TAIWAN IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. TAIWAN IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. THAILAND IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. THAILAND IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. THAILAND IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. VIETNAM IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. VIETNAM IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. VIETNAM IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 91. DENMARK IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. DENMARK IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. DENMARK IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. EGYPT IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. EGYPT IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. EGYPT IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. FINLAND IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. FINLAND IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. FINLAND IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. FRANCE IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. FRANCE IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. FRANCE IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. GERMANY IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. GERMANY IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. GERMANY IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. ISRAEL IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. ISRAEL IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. ISRAEL IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. ITALY IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. ITALY IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. ITALY IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. NETHERLANDS IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. NETHERLANDS IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. NETHERLANDS IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. NIGERIA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. NIGERIA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. NIGERIA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. NORWAY IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. NORWAY IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. NORWAY IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. POLAND IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. POLAND IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. POLAND IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. QATAR IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. QATAR IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. QATAR IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. RUSSIA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. RUSSIA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. RUSSIA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. SAUDI ARABIA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. SAUDI ARABIA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SAUDI ARABIA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH AFRICA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. SOUTH AFRICA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SOUTH AFRICA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. SPAIN IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. SPAIN IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. SPAIN IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. SWEDEN IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. SWEDEN IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. SWEDEN IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. SWITZERLAND IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. SWITZERLAND IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. SWITZERLAND IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. TURKEY IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. TURKEY IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. TURKEY IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED ARAB EMIRATES IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED ARAB EMIRATES IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED ARAB EMIRATES IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 151. UNITED KINGDOM IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. UNITED KINGDOM IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. UNITED KINGDOM IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 154. IMMUNOPROTEIN MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 155. IMMUNOPROTEIN MARKET, FPNV POSITIONING MATRIX, 2023